ダウンロード数: 2072
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
62_12_629.pdf | 918.17 kB | Adobe PDF | 見る/開く |
タイトル: | 前立腺癌ホルモン単独療法長期奏功例における治療中止後の臨床的検討 |
その他のタイトル: | Investigation on Clinical Course of Patients after Cessation of Long-Term Successful Hormone Monotherapy for Prostate Cancer |
著者: | 宇野, 雅博 ![]() 服部, 愼一 ![]() 加藤, 成一 ![]() 増栄, 成泰 ![]() 藤本, 佳則 ![]() |
著者名の別形: | Uno, Masahiro Hattori, Shinichi Kato, Seiichi Masue, Naruyasu Fujimoto, Yoshinori |
キーワード: | Prostate cancer Hormone monotherapy |
発行日: | Dec-2016 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 62 |
号: | 12 |
開始ページ: | 629 |
終了ページ: | 632 |
抄録: | We investigated the clinical course of patients after cessation of long-term successful hormone monotherapyfor prostate cancer. Studysubjects were ten patients with prostate cancer (localized prostate cancer ; n=8, prostate cancer with bone metastasis ; n=2), who had hormone monotherapyfor over seven years, showed no signs of recurrence, and maintained prostatic-specific antigen (PSA) levels of less than the detection sensitivitylimit (<0.01 ng/ml). The mean duration of hormone therapywas 101.1 months, and the mean duration of follow-up observation from cessation of the therapywas 31.1 months. PSA levels were maintained less than the detection sensitivitylimit in eight patients, and serum testosterone levels were equal to or less than the castration level in seven patients. This studydemonstrated that there were cases that maintained PSA levels of less than the detection sensitivitylimit even after cessation of long-term successful hormone monotherapyfor prostate cancer. |
著作権等: | 許諾条件により本文は2018/01/01に公開 |
DOI: | 10.14989/ActaUrolJap_62_12_629 |
URI: | http://hdl.handle.net/2433/217846 |
PubMed ID: | 28103656 |
出現コレクション: | Vol.62 No.12 |
![](/dspace/image/articlelinker.gif)
このリポジトリに保管されているアイテムはすべて著作権により保護されています。